Polygenic risk scores for the prediction of cardiometabolic disease

Jack W O'Sullivan1,2, Euan A Ashley1,2,3, Perry M Elliott4,5

  • 1Stanford Center for Inherited Cardiovascular Disease, Stanford University School of Medicine, Stanford, CA, USA.

European Heart Journal
|December 8, 2022
PubMed

Insights

Polygenic risk scores (PRSs) enhance prediction for cardiometabolic diseases like coronary artery disease and type 2 diabetes. While promising for conditions including atrial fibrillation, further research is needed for broader clinical use.

Area of Science:

  • Genetics and Precision Medicine
  • Cardiovascular and Metabolic Research

Background:

  • Cardiometabolic diseases are a leading cause of global morbidity and mortality.
  • Polygenic risk scores (PRSs) integrate multiple genetic variants to predict disease risk.
  • This review examines PRS utility across seven common cardiometabolic conditions.

Approach:

  • Systematic review of evidence for PRS in coronary artery disease (CAD), stroke, hypertension, heart failure, cardiomyopathies, obesity, atrial fibrillation (AF), and type 2 diabetes mellitus (T2DM).
  • Evaluation of PRS performance in improving clinical prediction models.

Key Points:

  • PRS for CAD, AF, and T2DM show consistent improvement in prediction when added to existing clinical risk tools.
  • PRS application for ischaemic stroke and hypertension is currently premature.
  • Larger, diverse populations and refined phenotyping are crucial for advancing PRS clinical utility.

Conclusions:

  • PRS represent a significant advancement in predicting cardiometabolic disease development and complications.
  • Clinical implementation of PRS is most robust for CAD, AF, and T2DM.
  • Future research directions include expanding PRS utility through diverse cohorts and detailed phenotyping.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
66.3K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
56
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
139
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
578